More recent functional studies have shown that METTL1 further drives glioma progression by catalysing m7G modification and stabilizing PGK1 mRNA, a glycolysis‐related enzyme, thereby enhancing glycolytic flux, accelerating cancer cells growth and survival in vivo.71 This evidence concerns the gene METTL1 and central nervous system cancer.